Raphaël Durand
Director/Board Member chez Axilum Robotics SAS
Profil
Raphaël Durand is currently the Director at Axilum Robotics SAS.
Previously, he served as the Chief Executive Officer at Echosens North America, Inc. from 2015 to 2019.
He was also the Director-Administrative & Finance at EuropaCorp SA from 2003 to 2011 and the Chief Financial Officer at EuropaCorp SA from 2003 to 2010.
Additionally, he served as the Chief Financial Officer & Joint Company Secretary at Echosens SA from 2014 to 2019.
Durand received his undergraduate degree from ESSEC Business School in 1993.
Postes actifs de Raphaël Durand
| Sociétés | Poste | Début |
|---|---|---|
Axilum Robotics SAS
 Axilum Robotics SAS Miscellaneous Commercial ServicesCommercial Services Axilum Robotics SAS develops and commercializes robotic solutions designed to assist medical professionals in the implementation of technical gestures. Its first project is a robot to assist psychiatrists and neurologists for Transcranial Magnetic Stimulation (TMS). The firm's project TMS is a painless, non invasive medical technique that applies high intensity magnetic impulses to cortex areas by placing a coil on the surface of the head. The company was founded by Bernard Bayle, Michel Berg, Michel de Mathelin, Romuald Ginhoux, Benjamin Maurin and Pierre Renaud in April 2011 and is headquartered in Strasbourg, France. | Director/Board Member | - |
Anciens postes connus de Raphaël Durand
| Sociétés | Poste | Fin |
|---|---|---|
Echosens North America, Inc.
 Echosens North America, Inc. Medical DistributorsDistribution Services Part of Inner Mongolia Furui Medical Science Co., Ltd., Echosens North America, Inc. is a private company that manufactures FibroScan®, a non-invasive solution that accurately measures liver stiffness and liver steatosis for a comprehensive management of liver disease. The company is based in Waltham, MA. The company's agile 4 (FibroScan®-based score) is a test for the identification of cirrhosis in NAFLD patients combining LSM by VCTE™ with blood biomarkers (AST, ALT, platelets). The company is shaping the future of liver health and empowering medical professionals to manage liver health for simpler, faster, and better patient care. Jon S. Gingrich has been the CEO of the company since 2019. | Chief Executive Officer | 27/08/2019 |
Echosens SA
 Echosens SA Medical SpecialtiesHealth Technology Echosens SA engages in the manufacture of medical imaging equipment. It focuses on developing FibroScan. The company was founded by Laurent Sandrin and Sylvain Yon on June 20, 2001 and is headquartered in Paris, France. | Director of Finance/CFO | 01/01/2019 |
| EUROPACORP | Chief Administrative Officer | 01/04/2011 |
| EUROPACORP | Director of Finance/CFO | - |
Formation de Raphaël Durand
| ESSEC Business School | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| EUROPACORP | Consumer Services |
| Entreprise privées | 3 |
|---|---|
Echosens SA
Echosens SA Medical SpecialtiesHealth Technology Echosens SA engages in the manufacture of medical imaging equipment. It focuses on developing FibroScan. The company was founded by Laurent Sandrin and Sylvain Yon on June 20, 2001 and is headquartered in Paris, France. | Health Technology |
Echosens North America, Inc.
Echosens North America, Inc. Medical DistributorsDistribution Services Part of Inner Mongolia Furui Medical Science Co., Ltd., Echosens North America, Inc. is a private company that manufactures FibroScan®, a non-invasive solution that accurately measures liver stiffness and liver steatosis for a comprehensive management of liver disease. The company is based in Waltham, MA. The company's agile 4 (FibroScan®-based score) is a test for the identification of cirrhosis in NAFLD patients combining LSM by VCTE™ with blood biomarkers (AST, ALT, platelets). The company is shaping the future of liver health and empowering medical professionals to manage liver health for simpler, faster, and better patient care. Jon S. Gingrich has been the CEO of the company since 2019. | Distribution Services |
Axilum Robotics SAS
Axilum Robotics SAS Miscellaneous Commercial ServicesCommercial Services Axilum Robotics SAS develops and commercializes robotic solutions designed to assist medical professionals in the implementation of technical gestures. Its first project is a robot to assist psychiatrists and neurologists for Transcranial Magnetic Stimulation (TMS). The firm's project TMS is a painless, non invasive medical technique that applies high intensity magnetic impulses to cortex areas by placing a coil on the surface of the head. The company was founded by Bernard Bayle, Michel Berg, Michel de Mathelin, Romuald Ginhoux, Benjamin Maurin and Pierre Renaud in April 2011 and is headquartered in Strasbourg, France. | Commercial Services |
